Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms - BioSpace
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms BioSpace
Merck & Co Company News
Merck & Co. (MRK) to acquire Terns Pharma for $6.7 billion - MSN
Merck & Co. (MRK) to acquire Terns Pharma for $6.7 billion MSN
Eastern Bank Sells 10,373 Shares of Merck & Co., Inc. $MRK - MarketBeat
Eastern Bank Sells 10,373 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck to buy Terns in $6.7B bet on a ‘differentiated’ leukemia drug - BioPharma Dive
Merck to buy Terns in $6.7B bet on a ‘differentiated’ leukemia drug BioPharma Dive
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline CNBC
Merck takes Terns | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Merck takes Terns | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Merck to Buy Terns for $6.7 Billion to Grow in Blood Cancers - Bloomberg.com
Merck to Buy Terns for $6.7 Billion to Grow in Blood Cancers Bloomberg.com
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports Reuters
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) - Business Wire
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) Business Wire
Merck & Co. to buy Terns for $6.7B, placing bet on CML therapy - FirstWord Pharma
Merck & Co. to buy Terns for $6.7B, placing bet on CML therapy FirstWord Pharma
Merck seals $5.7bn biotech deal to boost cancer drug pipeline - Financial Times
Merck seals $5.7bn biotech deal to boost cancer drug pipeline Financial Times
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience - FinancialContent
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience FinancialContent
Merck's Deal For Terns And Its Stellar CML Drug Candidate Looks Like Good Business (MRK) - Seeking Alpha
Merck's Deal For Terns And Its Stellar CML Drug Candidate Looks Like Good Business (MRK) Seeking Alpha
Our Q4 and full-year 2025 financial results - Merck.com
Our Q4 and full-year 2025 financial results Merck.com
Merck & Co., Inc. $MRK Shares Sold by Advisors Management Group Inc. ADV - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Advisors Management Group Inc. ADV MarketBeat
Merck braces for Keytruda patent loss with $6.7 billion Terns bet - Reuters
Merck braces for Keytruda patent loss with $6.7 billion Terns bet Reuters
Merck to split cancer, specialty drug businesses in leadership shakeup - BioPharma Dive
Merck to split cancer, specialty drug businesses in leadership shakeup BioPharma Dive
Merck & Co., Inc. $MRK Stock Holdings Cut by Hunter Perkins Capital Management LLC - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Cut by Hunter Perkins Capital Management LLC MarketBeat
Exchange Traded Concepts LLC Buys 219,579 Shares of Merck & Co., Inc. $MRK - MarketBeat
Exchange Traded Concepts LLC Buys 219,579 Shares of Merck & Co., Inc. $MRK MarketBeat
Global X Japan Co. Ltd. Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Global X Japan Co. Ltd. Takes Position in Merck & Co., Inc. $MRK MarketBeat
Ferguson Wellman Capital Management Inc. Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Ferguson Wellman Capital Management Inc. Grows Stake in Merck & Co., Inc. $MRK MarketBeat
Dakota Wealth Management Has $19.04 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Dakota Wealth Management Has $19.04 Million Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Fort Washington Investment Advisors Inc. OH - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Fort Washington Investment Advisors Inc. OH MarketBeat
Parsons Capital Management Inc. RI Sells 14,477 Shares of Merck & Co., Inc. $MRK - MarketBeat
Parsons Capital Management Inc. RI Sells 14,477 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Synergy Asset Management LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Synergy Asset Management LLC MarketBeat
The new manufacturing facilities powering our US growth - Merck.com
The new manufacturing facilities powering our US growth Merck.com
From failure to hit to a $6.7 billion buyout: Terns Pharma gets big offer from Merck - The Business Journals
From failure to hit to a $6.7 billion buyout: Terns Pharma gets big offer from Merck The Business Journals
Merck to acquire Terns Pharmaceuticals for $6.7B - Proactive financial news
Merck to acquire Terns Pharmaceuticals for $6.7B Proactive financial news
Merck & Co., Inc. $MRK Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Assenagon Asset Management S.A. MarketBeat
SeaCrest Wealth Management LLC Buys 11,454 Shares of Merck & Co., Inc. $MRK - MarketBeat
SeaCrest Wealth Management LLC Buys 11,454 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline - BioSpace
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline BioSpace
Pensionfund Sabic Makes New $3.05 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Pensionfund Sabic Makes New $3.05 Million Investment in Merck & Co., Inc. $MRK MarketBeat
Central Bank & Trust Co. Sells 13,216 Shares of Merck & Co., Inc. $MRK - MarketBeat
Central Bank & Trust Co. Sells 13,216 Shares of Merck & Co., Inc. $MRK MarketBeat
E. Ohman J or Asset Management AB Purchases Shares of 88,457 Merck & Co., Inc. $MRK - MarketBeat
E. Ohman J or Asset Management AB Purchases Shares of 88,457 Merck & Co., Inc. $MRK MarketBeat
Girding against Keytruda cliff, Merck splits oncology into standalone business unit - Fierce Pharma
Girding against Keytruda cliff, Merck splits oncology into standalone business unit Fierce Pharma
Merck Vaccine Sales Drop as US Declines Strike Another Pharma - BioSpace
Merck Vaccine Sales Drop as US Declines Strike Another Pharma BioSpace
Merck & Co (MRK) to Generate $70 Billion in Revenue from Emerging Businesses By Mid-2030s - Yahoo Finance
Merck & Co (MRK) to Generate $70 Billion in Revenue from Emerging Businesses By Mid-2030s Yahoo Finance
Merck's 2026 outlook clouds upbeat fourth-quarter results - Reuters
Merck's 2026 outlook clouds upbeat fourth-quarter results Reuters
Clear Trail Advisors LLC Makes New $7.97 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Clear Trail Advisors LLC Makes New $7.97 Million Investment in Merck & Co., Inc. $MRK MarketBeat
Merck & Co pharmaceutical revenue by therapeutic class 2025 - Statista
Merck & Co pharmaceutical revenue by therapeutic class 2025 Statista